Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Conference Documentation: Gene Therapy

Published by: SMI Publishing, Ltd

Published: Feb. 27, 2002


Table of Contents


DAY ONE

8.30 Registration and Coffee

9.00 Chairman's Opening Remarks

Dr Dominic Wells, Reader in Transgenic Biology, Imperial College of Science, Technology & Medicine

9.10 OVERVIEW

Status and issues for further development

Dr Andrew Mountain, Research Director, Cobra Therapeutics

9.40 GENE THERAPY PRODUCTS

Where, when and how?

Dr Douglas Jolly, Chief Executive Officer, BioMedica

10.20 LOCALIZED PRODUCTION OF THERAPEUTIC PROTEINS AT THE SITE OF DISEASE

Considerations

Dr Richter King, Vice President, Research, GenVec

11.00 Morning Coffee

11.20 UNDERSTANDING THE VECTOR-GENE-DISEASE RELATIONSHIP

Gene Therapy hurdles

Dr James McArthur, Principal Scientist, Senior Director, Preclinical Biology and Immunology, Cell Genesys

12.00 HURDLES IN GENE THERAPY DELIVERY

Use of capsid-modified adenoviral vector for vaccination purposes

Dr Ronald Vogels, Senior Scientist, Crucell

12.40 Networking Lunch

2.00 TRANZVECTOR - A NEXT GENERATION LENTIVIRAL VECTOR WITH ENHANCED SAFETY

Applications to neuro-ophthalmic diseases

Dr Ram Ramabhadran, Senior Vice President, Research & Development, Tranzyme

2.40 THE FUTURE OF PROTEIN DELIVERY

The perfect implement to small molecule drugs

Dr Albert Rauch, Managing Director, Ladenburg Thalmann

3.20 Afternoon Tea

3.40 ALTERNATIVE VECTORS FOR GENE THERAPY

Synthetic gene delivery: another quest for the holy grail?

Dr Alain Rolland, Senior Vice President, Preclinical Research & Development, Valentis

4.20 GENE DELIVERY AND VACCINES

Novel viral vectors

Dr Christian Hofmann, Vice President, Vector Development, DeveloGen

5.00 Chairman's Closing Remarks and Close of Day One

DAY TWO

8.30 Re-registration and Coffee

9.00 Chairman's Opening Remarks

Dr Hardev Pandha, Senior Lecturer in Medical Oncology, St George’s Hospital Medical School

9.10 DISEASE TARGETED RESEARCH

Cardiovascular diseases

Dr Jack Reich, Chief Executive Officer & Chairman, Collateral Therapeutics

9.40 PRE-CLINICAL AND CLINICAL STUDIES WITH ONYX-015: CURRENT PROGRESS AND FUTURE POTENTIAL

Cancer therapies

Dr Scott Freeman, Vice President, Clinical Development, Onyx Pharmaceuticals

10.20 DEVELOPING GENE MEDICINES

Recent experience

Dr Alan Boyd, Director, Development, Ark Therapeutics

11.00 Morning Coffee

11.20 THERAPEUTIC ACTIVATION OF ENDOGENOUS GENES

Target genes

Dr John Girdlestone, Senior Scientist, Gendaq Ltd.

12.00 TARGET VALIDATION

Tissue proteomics in the discovery process

Dr Julian Beesley, Director, Business Development, LifeSpan BioSciences

12.40 Networking Lunch

2.00 FROM THE BENCH TO THE PHARMACY

Which products will make it first

Dr Claas Junghans, General Manager, Mologen

2.40 FROM CONCEPT TO COMMERCIALISATION

Marketing the product

Dr Samuel Wadsworth, Vice President, Gene Therapy Initiative, Genzyme

3.20 Afternoon Tea

3.40 REGULATIONS

The regulatory oversight of gene therapy

Dr Jayne Spink, Section Head, Genetic Science Policy, Gene Therapy Advisory Committee, Department of Health, UK

4.20 THE FUTURE OF GENE THERAPY

The next steps

Dr Barrie Carter, Chief Scientific Officer, Targeted Genetics

5.00 Chairman's Closing Remarks and Close of Conference



Abstract

Missed an SMi Conference? Of course nothing compares with being there. But if you missed the recent SMi Conference on Gene Therapy did you know you can still benefit from the event?

What the information package includes:

  • pages of presentations
  • the latest trends, industry data, forecasts, market analysis, competitor information, and much, much more.

    Events are now available on CD-ROM, via .pdf, in hardcopy documentation and on audiocassette. There's no need to miss out on any key industry conferences - whether you could not make the dates, or you got tied up in last minute business meetings, you and your colleagues can still benefit. Take this unique opportunity to benefit from the market leaders' strategies. You can work through the conference materials at your leisure, whenever you want. The packages are now available in hardcopy or electronically. All conference documentation packages are dispatched once payment has been received after the event. Order online today to secure your copy.

    Conference documentation features all the PowerPoint presentations and handouts from the event. Whether you're writing a report based on the latest industry trends, training colleagues or undertaking research, the documentation offers an invaluable source of leading edge knowledge.

    Or capture all of the information presented at our conferences on professionally recorded audiocassettes. Your purchase includes a permanent reference of audiocassettes and the complete conference workbook.

    Get Full Details About This Report >>

  • US: 800.298.5699
    Int'l: +1.240.747.3093
    Buy this Report

    Price and Delivery Options

    See related reports or call the number above for help from a research specialist.


    advertise with us

     

    About MarketResearch.com
    MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

     

    © MarketResearch.com 2008